SEROLOGICAL RESPONSES AFTER SARS‐COV‐2 VACCINATION FIRST DOSE IN PATIENTS WITH LYMPHOID MALIGNANCY: FIRST INTERIM ANALYSIS OF THE UK PROSECO STUDY. (17th June 2021)

• Record Type: Journal Article
• Authors: Lim, S.H.; Campbell, N.; Joseph‐Pietras, D.; Johnson, M.; Mundy, C.; Coleman, H.; Wynn, T.; Maynard, B.; Lown, R.; Bates, A.; Wetherall, N.; Muller, D.; Falconer, J.; Fox, C.; Collins, G.; O'Callaghan, A.; Willimott, V.; Ahearne, M.; Faust, S.N.; Johnson, P.W.; Goldblatt, D.; Davies., A.J.
• Is Part Of: Hematological oncology. Volume 39(2021)Supplement 2
• Page Start: n/a
• Page End: n/a
• Publication Date: 2021-06-17
• Subjects: Hematological oncology -- Periodicals; Hematology; Medical Oncology; 616.99418005
• DOI: 10.1002/hon.198_2880
• Languages: English
• ISSNs: 0278-0232